Wealth host Brad Smith outlines some of today's trending stories. Target (TGT) was downgraded to Underperform from Market Perform by Bernstein analysts, citing the retailer's "difficult trade-off" between sales and margins. Astera Labs (ALAB) was upgraded to Overweight by Morgan Stanley, saying the stock's recent decline is a good entry point. Kindly MD (KDLY) stock skyrockets after announcing a merger with Nakamoto Holdings. To watch more expert insights and analysis on the latest market action, check out more Wealth here. Video Transcript 00:00 News Anchor Now time for some of today's trending tickers. We are watching Target, A stellar labs, and kindly MD. First up, target downgraded to underperform from market perform at Bernstein. The analyst says that the retailer faces a difficult trade-off between fueling sales growth and maintaining margins. Bernstein says target is losing market share in core discretionary categories like home and apparel, and that e-commerce growth could be a persistent margin headwind for Target. The analyst says poor weather, weak consumer sentiment and a DEI related strike in March weighed on first quarter results, and that tariff risks aren't fully priced in. Next up here we've got A stellar labs, getting an upgrade to overweight at Morgan Stanley. This is following the chip manufacturing company's quarterly results. The firm says recent weakness in the stock represents a good entry point despite the stock being quote highly polarizing. The analyst cites AI optimism, saying they believe there is too much pessimism in AI, and says new products should give the company sustained growth. And finally here, healthcare Services company Kindly MD, surging the most on record on an agreement to merge with Bitcoin holding company, Nakamoto Holdings to start a Bitcoin treasury strategy here. Nakamoto was founded by David Bailey, a crypto advisor to President Trump, and the merger includes $510 million in private investment, $200 million in convertible notes. Related Videos 02:40 Wall St. Brokers Risk Losing Billions in Fees on SEC Shift Bloomberg • 49 minutes ago 02:11 Trump Says He Thinks Apple Will Increase US Investment Bloomberg • 1 hour ago 01:03 Retail gains, Wayfair upgrade, NRG Energy $12 billion deal Yahoo Finance Video • 1 hour ago 00:56 Oil prices rise, gold slips, Kindly MD-Nakamoto merger Yahoo Finance Video • 2 hours ago View Comments
Target, Astera Labs, Kindly MD: Trending Tickers
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...